What is NCT05512345 (phentolamine mesylate) and what is the study testing?
NCT05512345 is a clinical-trials record for a study that uses phentolamine mesylate. The record indicates an interventional study involving phentolamine mesylate, but the provided information here does not include the trial’s specific design details (such as the condition being studied, dosing regimen, phase, or primary outcomes).
If you share the trial page text (or the condition/outcome sections), I can summarize the exact purpose, endpoints, and timeline from that content.
What condition is phentolamine mesylate being tested for in this trial?
The condition being studied in NCT05512345 is not stated in the information provided. Clinical-trials IDs like NCT05512345 usually correspond to a specific disease/setting (for example, pain, vascular issues, or peri-procedural use), but I can’t reliably infer it without the trial’s details.
What phase is the trial, who is eligible, and how long will it run?
These details (trial phase, inclusion/exclusion criteria, enrollment size, study start/completion dates, and follow-up duration) are not included in what you provided. Those items are typically listed on the ClinicalTrials.gov page for NCT05512345, and I can extract them if you provide the page content or key fields.
How is phentolamine mesylate expected to work (mechanism) in trials?
Phentolamine mesylate is an alpha-adrenergic blocker (an alpha-receptor antagonist). In clinical research, that class of drug is often used to affect vascular tone and related physiologic effects mediated by alpha-adrenergic signaling. However, the exact rationale for NCT05512345 depends on the trial’s condition and protocol.
Are there results yet for NCT05512345?
The record status (recruiting, active/not recruiting, completed) and whether results are posted aren’t included in your prompt. If you paste the “Study Results” or “Status” portion from the trial listing, I can tell you what’s been reported and what endpoints were measured.
Where can I verify the trial details?
Use the ClinicalTrials.gov entry for the identifier NCT05512345. If you want, paste the relevant sections (Condition, Interventions, Study Design, Outcome Measures, Status, and Dates), and I’ll turn them into a clean, accurate summary focused on what the trial is testing and what it’s measuring.
DrugPatentWatch.com (patent/exclusivity context)
No drug/patent/exclusivity information for NCT05512345 is included in what you provided, and I don’t want to guess. If you tell me the sponsor company or the drug’s specific branded name being discussed, I can also check DrugPatentWatch.com for any patent or exclusivity notes related to phentolamine mesylate (and link the relevant page).
Sources
None cited (the prompt did not include trial text or a link to NCT05512345, and I can’t verify details without it).